The NEXT-1 (Next generation pErsonalized tX with mulTi-omics and preclinical model) trial: prospective molecular screening trial of metastatic solid cancer patients, a feasibility analysis

We conducted a prospective genomic screening trial with high throughput sequencing and copy number variation (CNV) assay, and immunohistochemistry array in metastatic solid cancer patients. We used Ion AmpliSeq Cancer Hotspot Panel v2 and nCounter Copy Number Variation Assay (21 genes) to identify m...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Oncotarget
Asıl Yazarlar: Kim, Seung Tae, Lee, Jeeyun, Hong, Mineui, Park, Kyunghee, Park, Joon Oh, Ahn, Tae Jin, Park, Se Hoon, Park, Young Suk, Lim, Ho Yeong, Sun, Jong-Mu, Ahn, Jin Seok, Ahn, Myung-Ju, Kim, Hee Cheol, Sohn, Tae Sung, Choi, Dong Il, Cho, Jong Ho, Heo, Jin Seok, Kwon, Wooil, Uhm, Sang Won, Lee, Hyuk, Min, Byung-Hoon, Hong, Sung No, Kim, Duk Hwan, Jung, Sin Ho, Park, Woongyang, Kim, Kyoung-Mee, Kang, Won Ki, Park, Keunchil
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Impact Journals LLC 2015
Konular:
Research Paper
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4741771/
https://ncbi.nlm.nih.gov/pubmed/26396172
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller